Pharma company (PC) is a biopharmaceutical company leveraging an outstanding level of knowledge and experience in RNA interference (RNAi) technology to forge a path to high value creation through discovery and development of therapeutics for human disorders with unmet medical needs.
We are mastering a key and unique technique for small interfering RNA drug delivery. Through the internal research and collaborations with prominent labs, we have developed a strong portfolio of intellectual property covering RNAi therapeutic products.
PC has brought together a team of experienced and dedicated leaders in genetic medicines to translate our technology platform into treatments for patients. The management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on severe diseases and a robust intellectual property portfolio.
Common value orientation, excellent capabilities, and complementary relationships must be the cornerstones of a strong partnership. With advanced technology platform and professional development capabilities, we look forward to working closely with more partners around the world to promote the development of gene silencing therapy.
Pushing the boundaries for life science research
Pharma company is on a mission to advance our proprietary platform for gene therapy and to transform the lives of patients through effective therapies.
Copyright © Acevirt. All rights reserved.